Associations between soluble PD-L1/PD-1 and circulating immune cells for prostate cancer progression

被引：0
|
作者：
Survila, Zilvinas [1 ]
Pasukoniene, Vita [2 ]
Zvirble, Margarita [2 ,3 ]
机构：
[1] Vilnius Univ, Life Sci Ctr, Inst Biosci, Vilnius, Lithuania
[2] Natl Canc Inst, Vilnius, Lithuania
[3] Vilnius Univ, Life Sci Ctr, Vilnius, Lithuania
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2024年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
2251 - P3.
引用
收藏
页码：1630 / 1630
页数：1
相关论文
共 50 条
  • [1] Immunohistochemistry of Immune Checkpoint Markers PD-1 and PD-L1 in Prostate Cancer
    Sharma, Meenal
    Yang, Qi
    Mcmahon, Loralee
    Miyamoto, Hiroshi
    MODERN PATHOLOGY, 2019, 32
  • [2] Immunohistochemistry of Immune Checkpoint Markers PD-1 and PD-L1 in Prostate Cancer
    Sharma, Meenal
    Yang, Qi
    Mcmahon, Loralee
    Miyamoto, Hiroshi
    LABORATORY INVESTIGATION, 2019, 99
  • [3] Immunohistochemistry of immune checkpoint markers PD-1 and PD-L1 in prostate cancer
    Sharma, Meenal
    Yang, Zhiming
    Miyamoto, Hiroshi
    MEDICINE, 2019, 98 (38)
  • [4] Measurement of soluble PD-1 and soluble PD-L1 as well as PD-L1 and PD-1 from perioperative patients with gastric carcinoma
    Wei, Hangzhi
    Wu, Fahong
    Mao, Yudong
    Zhang, Youcheng
    Leng, Guangxian
    Wang, Jia
    Zhang, Wei
    Wang, Tianwei
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (04) : 331 - 345
  • [5] Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer
    Niu, Mengke
    Liu, Yiming
    Yi, Ming
    Jiao, Dechao
    Wu, Kongming
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [6] Soluble PD-L1 levels correlate with efficacy of PD-1/PD-L1 inhibitors in lung cancer
    Kang, Da Hyun
    Koh, Jeong Suk
    Chung, Chaeuk
    Park, Dongil
    Lee, Song-I
    Lee, Jeong Eun
    RESPIROLOGY, 2023, 28 : 99 - 99
  • [7] The clinical significance of soluble PD-1 and PD-L1 in lung cancer
    Abu Hejleh, Taher
    Furqan, Muhammad
    Ballas, Zuhair
    Clamon, Gerald
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 143 : 148 - 152
  • [8] Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer
    Zhu, Xinxin
    Lang, Jinghe
    ONCOTARGET, 2017, 8 (57) : 97671 - 97682
  • [9] PD-1/PD-L1 axis: implications in immune regulation, cancer progression, and translational applications
    Ortega, Miguel A.
    Boaru, Diego Liviu
    De Leon-Oliva, Diego
    Fraile-Martinez, Oscar
    Garcia-Montero, Cielo
    Rios, Laura
    Garrido-Gil, Maria J.
    Barrena-Blazquez, Silvestra
    Minaya-Bravo, Ana M.
    Rios-Parra, Antonio
    Alvarez-Mon, Melchor
    Jimenez-Alvarez, Laura
    Lopez-Gonzalez, Laura
    Guijarro, Luis G.
    Diaz, Raul
    Saez, Miguel A.
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2024, 102 (08): : 987 - 1000
  • [10] PD-1/PD-L1 immune checkpoints: Tumor vs atherosclerotic progression
    Liang, Yamin
    Li, Lu
    Chen, Yanmei
    Xiao, Jinyan
    Wei, Dangheng
    CLINICA CHIMICA ACTA, 2021, 519 : 70 - 75
12345